• Sorry! To unlock all site features, we'll need to collect some information from you.
  • Unit 8.4: New Drug-Eluting Stents Trials

    Alexandre Abizaid, MD, PhD — Instituto Dante Pazzanese de Cardiologia and Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour


    Faculty Disclosure

    Disclosures not available


    Learning Objectives

    • Drug-eluting stent components
    • Active agent mechanism of action and kinetics
    • Results of clinical, angiographic, and intravascular ultrasound studies
    • Frequency of restenosis and late lumen loss with new drug-eluting stents
    • Insight into specific strength/value for each system